Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001213900-23-059363
Filing Date
2023-07-25
Accepted
2023-07-25 06:02:06
Documents
22

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2267654
2 filename2.htm EX-23.2 1985
3 GRAPHIC image_001.jpg GRAPHIC 2705
4 GRAPHIC image_002.jpg GRAPHIC 4031
5 GRAPHIC image_003.jpg GRAPHIC 11086
6 GRAPHIC image_004.jpg GRAPHIC 11086
7 GRAPHIC image_005.jpg GRAPHIC 12417
8 GRAPHIC image_006.jpg GRAPHIC 8480
9 GRAPHIC image_007.jpg GRAPHIC 6970
10 GRAPHIC image_008.jpg GRAPHIC 14055
11 GRAPHIC image_009.jpg GRAPHIC 2307
12 GRAPHIC image_010.jpg GRAPHIC 8385
13 GRAPHIC image_011.jpg GRAPHIC 8924
14 GRAPHIC image_012.jpg GRAPHIC 9239
15 GRAPHIC image_013.jpg GRAPHIC 3157
16 GRAPHIC image_014.jpg GRAPHIC 16479
17 GRAPHIC image_015.jpg GRAPHIC 38870
18 GRAPHIC image_016.jpg GRAPHIC 1305
19 GRAPHIC image_017.jpg GRAPHIC 1305
20 GRAPHIC image_018.jpg GRAPHIC 28535
21 GRAPHIC fin_001.jpg GRAPHIC 13635
22 GRAPHIC fin_002.jpg GRAPHIC 1699
  Complete submission text file 0001213900-23-059363.txt   2555305
Mailing Address 630 PENA DRIVE, SUITE 400 DAVIS CA 95618
Business Address 630 PENA DRIVE, SUITE 400 DAVIS CA 95618 778-558-4949
Elevai Labs Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-06605 | Film No.: 231106341
SIC: 2834 Pharmaceutical Preparations